Acrivon Therapeutics, Inc.
ACRV
NASDAQ
Headlines
There are no news to display.
Filings
Thursday, November 9, 2023
Saturday, September 30, 2023
(est)
Price History
--
--
--
--
Business Description
Acrivon Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing oncology medicines for the patients whose tumors are predicted to be sensitive to each specific...
more